8-K
Current Report
Inmune Bio, Inc. Filed Acc 0001213900-24-106919
Material agreement · Shareholder rights changed · Executive or director change
- Item 1.01 Entry into a material definitive agreement
- Item 3.03 Material modification to rights of security holders
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading ea0223776-8k_inmune.htm…